Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations
Xiao-Ying Zhao,1 Hui-Min Xu,2 Quan Zhou2 1The Medical Ethics Committee, 2Department of Pharmacy, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of ChinaWe read with great interest the study by Del Tacca et al,1 who perf...
Saved in:
Main Authors: | Zhao XY (Author), Xu HM (Author), Zhou Q (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the bioequivalence of levetiracetam brand and generic oral tablets available in the Saudi market in vivo
by: Danah ALRabeeah, et al.
Published: (2023) -
Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects Under Fasting and Fed Conditions
by: Wang MN, et al.
Published: (2021) -
Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers
by: Del Tacca M, et al.
Published: (2013) -
BIOEQUIVALENCE STUDY OF GENERIC MOLNUPIRAVIR IN HEALTHY VOLUNTEERS
by: V. B. Vasilyuk, et al.
Published: (2023) -
Bioequivalence study of generic nirmatrelvir in healthy volunteers
by: R. A. Oseshnyuk, et al.
Published: (2023)